Trials / Active Not Recruiting
Active Not RecruitingNCT06539429
Clinical Study to Evaluate Efficacy and Safety of ANT-301 in Patients With Knee Osteoarthritis in Grade III/IV by K/L
Phase I Clinical Study to Evaluate Safety and Efficacy of ANT-301 in Knee Osteoarthritis Patients
- Status
- Active Not Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (estimated)
- Sponsor
- Anterogen Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This is a phase I open study to evaluate the efficacy and safety of ANT-301 in patients with knee osteoarthritis K\&L Grade III/IV.
Detailed description
Study Design: open-label, single-center, dose-escalation study
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | ANT-301 | Administration on Day 1 |
Timeline
- Start date
- 2024-10-22
- Primary completion
- 2026-05-15
- Completion
- 2026-05-15
- First posted
- 2024-08-06
- Last updated
- 2025-09-22
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06539429. Inclusion in this directory is not an endorsement.